A key precedent may sustain negotiation to keep down Medicare drug prices

Forbes

1 July 2022 - Medicare drug price negotiation, which holds down prices, may emerge from the long-quiet Senate negotiations on an omnibus policy (“Build Back Better”) bill. 

On this issue, there has been a back-room discussion between the Majority Leader, Chuck Schumer, and Senator Joe Manchin, who has always has the one vote making a majority vital for passage. A key point will be the thumbs-up from the Senate Parliamentarian. 

That depends on the precedents.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing